← All investors

Oxford Science Enterprises

VC🇬🇧 United Kingdom

Investment thesis

Independent GBP 850m+ investment company created in 2015 to found, fund and build transformational businesses via a unique partnership with the University of Oxford, under which Oxford is a shareholder and OSE typically receives half the university's equity in a spinout. Focuses on a core portfolio across Life Sciences, HealthTech and Deep Tech.

Notable portfolio

Oxford IonicsAlethio TherapeuticsDark Blue TherapeuticsWild BioscienceOxford Nanopore

Sector focus

Life sciencesHealthDeep TechQuantumAIFusionRoboticsBiotech